These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20627367)

  • 1. Real-time validation and presentation of the cumulative antibiogram and implications of presenting a standard format using a novel in-house software: ABSOFT.
    Wilson G; Badarudeen S; Godwin A
    Am J Infect Control; 2010 Nov; 38(9):e25-30. PubMed ID: 20627367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case studies of bacterial species responsible for urinary tract infections and their sensitivity to antibiotic treatment].
    Dominici C; Morozzi B
    Minerva Chir; 1978 Dec 15-31; 33(23-24):1745-62. PubMed ID: 740260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antibiogram for hospitals with 50+ beds--Alaska, 2002.
    Castrodale L; Hennessy T
    Alaska Med; 2004; 46(4):81-7. PubMed ID: 15999909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiograms of pathogenic bacteria isolated from laboratory rabbits in Ibadan, Nigeria.
    Okewole EA; Olubunmi PA
    Lab Anim; 2008 Oct; 42(4):511-4. PubMed ID: 18840619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is inadequate antibacterial therapy?
    Moellering RC
    Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
    [No Abstract]   [Full Text] [Related]  

  • 6. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doripenem: an early look at a carbapenem not yet approved for pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 2010 Feb; 29(2):163-5. PubMed ID: 20135831
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antibiogram in hospital practice. Its necessity and usefulness].
    Gambella O
    Quad Sclavo Diagn; 1979 Mar; 15(1):124-32. PubMed ID: 542590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the antibiogram of primary and subcultures in diagnosing acute bronchopulmonary infections].
    Buiuc D; Burcoveanu C
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(4):663-8. PubMed ID: 6537634
    [No Abstract]   [Full Text] [Related]  

  • 10. Early diagnosis and therapy of bacterial corneal ulcers.
    Jones DB
    Int Ophthalmol Clin; 1973; 13(4):1-29. PubMed ID: 4784000
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nature and antibiotic resistance of bacteria encountered in an intensive care unit. Computerized study based on 422 antibiograms].
    du Cailar J; Griffe O; Despaux E; Gartner R; Kienlen J; Chardon P; Perez C
    Ann Anesthesiol Fr; 1979; 20(6-7):633-46. PubMed ID: 44978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics of choice for clinically important bacteria.
    Jeljaszewicz J
    Adv Clin Pharmacol; 1974; 8():89-95. PubMed ID: 4468734
    [No Abstract]   [Full Text] [Related]  

  • 13. A rational approach to the selection of an antimicrobial agent.
    Hirsh DC; Ruehl WW
    J Am Vet Med Assoc; 1984 Nov; 185(10):1058-61. PubMed ID: 6392230
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaerobic infections (third of three parts).
    Gorbach SL; Bartlett JG
    N Engl J Med; 1974 Jun; 290(23):1289-94. PubMed ID: 4597253
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plectasin - a new peptide antibiotic with high therapeutic potential].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Sep; 39(5):336-8. PubMed ID: 20818681
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro evaluation of "piperacillin and tazobactum" combination in a tertiary-care hospital--a preliminary study.
    Kumari N; Mohapatra TM; Rai A; Bhattacharya SK
    Indian J Pathol Microbiol; 2006 Jan; 49(1):57-8. PubMed ID: 16625981
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibiotic sensitivity of microbial strains isolated from the hospital environment].
    Debeleac L; Voicescu V; Dumitrescu MR; Covacu A; Slavov N; Georgescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(3):225-34. PubMed ID: 3438652
    [No Abstract]   [Full Text] [Related]  

  • 19. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
    Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE
    Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obtention of bacterial antibiotic susceptibility following standard conditions directly from infected biological fluids and positive blood cultures].
    Noussair L; Nicolas-Chanoine MH
    Pathol Biol (Paris); 2007; 55(3-4):143-8. PubMed ID: 17046171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.